ATOMUSD ATOM/USD
- 4.855
- +0.086+1.80%
Cosmos Exploration Limited Announces Quotation of 20 Million New Securities
Cosmos Exploration Advances in Bolivia's Lithium Sector
Is ATOM's Price Ready for Its Next Uptrend? Key Signals, Indicators Say...
Cosmos Health Enters Final Development Phase Of CCX0722 Weight Management Solution
Cosmos Health Announces Filing Of Two New Patent Applications For Glioma And Hematologic Malignancies Treatment; Advances Stem From AI-Powered Drug Repurposing And Collaborations With Cloudpharm And National Hellenic Research Foundation
Cosmos Health Strengthens Management Team With the Appointment of Veteran Executive Dimitris Moraitis as Vice President of Strategy & Operations
Cosmos Health's Cana Labs Signs 10-Year Manufacturing Deal With Provident Pharmaceuticals
Cosmos Initia 9-Mos Net Y3.94B Vs Net Y1.63B
Cosmos Initia Sees FY Net Y5.20B
Cosmos Health Receives $578,460 Initial Purchase Order From Al Rabwa International For Sky Premium Life Food Supplements In Qatar; The Initial Purchase Order Covers 35 Of The Company's 79 SKUs
Cosmos Health Files Patent Application for Multiple Sclerosis Treatment
Express News | Cosmos Health Files AI-Driven Patent Application Number N2039644 For Multiple Sclerosis Treatment
Cosmos Exploration Plans New Securities Issue to Bolster Capital
Cosmos Exploration Secures A$1.25 Million to Advance Lithium Acquisition
Cosmos Exploration Limited Initiates Trading Halt Ahead of Key Announcement
Nvidia's Next Big Bet: The Fusion of Omniverse and Cosmos
Cosmos Exploration Limited Announces Cessation of Certain Securities
Cosmos Health Secures Bond Loan From European Bank on Very Competitive Terms, With Option to Upsize to Support Growth and Achieve Positive Operating Cash Flow
Cosmos Exploration Eyes Bolivia's Lithium for Sustainable Growth
Cosmos Health Files New Patent Application For Allergic Inflammation Therapy